As long as the status of alcohol consumption as an enjoyable and even beneficial recreation remains, not least via the multitude of advertising outlets globally, the alcohol industry will be free to exert its nefarious influence while policymakers turn a blind eye. The evidence for alcohol’s harms, and the efforts of industry to obscure it, have never been clearer. The Action Plan should be endorsed in full and swiftly followed by preparations for a Framework Convention.

Author

The Lancet Global Health

Citation

The Lancet Global Health, 2022. Clearing our heads over alcohol. The Lancet Global Health, 10(3), p.e298.


Source
The Lancet Global Health
Release date
01/03/2022

Clearing Our Heads Over Alcohol

Summary

“Alcohol is the only psychoactive and dependence-producing substance that exerts a significant impact on global population health that is not controlled at the international level by legally binding regulatory instruments”. This statement formed part of the preamble of a draft Action Plan for implementing the WHO Global Strategy to Reduce the Harmful Use of Alcohol, which was recommended at the recent WHO Executive Board meeting for adoption at the next World Health Assembly.

As a reminder of the consequences, alcohol use was the seventh leading risk factor for both death and disability-adjusted life-years (DALYs) in 2016, according to the Global Burden of Disease (GBD) study, accounting for 6.8% of age-standardized male deaths and 2.2% of age-standardized female deaths. Among the population aged 15–49 years, it was the leading risk factor globally, leading to 12.2% of male deaths and 3.8% of female deaths. These harms do not, of course, include indirect harms caused by driving under the influence of alcohol, violence, and alcohol consumption during pregnancy, nor the related social and financial effects. Notably, the GBD study concluded that “consuming zero standard drinks daily minimized the overall risk of all health loss”—a position echoed by the World Heart Federation in January.

The draft Action Plan approved at the 150th WHO Executive Board session in January was drawn up in light of the limited policy traction seen, particularly in low-income and middle-income countries, since the Global Strategy to Reduce the Harmful Use of Alcohol was endorsed in 2010. One of the key barriers, according to the Action Plan preamble, is industry interference in alcohol policy development and implementation and governments’ reluctance to resist it, whether from weak leadership or competing interests.

Ironically, the Action Plan itself seems to have been subject to such interference, according to a report from the Centre for Alcohol Policy Research at La Trobe University, Melbourne, Australia. The report’s authors examined submissions to WHO’s online consultation on the draft Action Plan in 2020, finding that 60 (24%) of 251 submissions were from alcohol industry actors.

An analysis of before-and-after versions of the draft Action Plan by the Foundation for Alcohol Research and Education showed that one of the global targets had been changed from a reduction in per capita alcohol consumption to a reduction in the “harmful use of alcohol”, and that reference to “self-regulation” by industry had been inserted.

Pepita Barlow and colleagues analyzed statements made at key World Trade Organization committee meetings regarding alcohol warning labels between 2010 and 2019 and found that more than half of such statements echoed stances put forward elsewhere by the alcohol industry, despite only 3% being clearly identified as such.

As long as the status of alcohol consumption as an enjoyable and even beneficial recreation remains, not least via the multitude of advertising outlets globally, the alcohol industry will be free to exert its nefarious influence while policymakers turn a blind eye. The evidence for alcohol’s harms, and the efforts of industry to obscure it, have never been clearer. The Action Plan should be endorsed in full and swiftly followed by preparations for a Framework Convention.


Source Website: The Lancet